Ponatinib-Associated Cutaneous Eruptions-A Case Series and
2023年1月1日 · Cutaneous toxicities are a commonly reported side effect of ponatinib treatment with "rash" being one of the most common. Specific subtypes are infrequently reported, but …
A patient with maculopapular rash and lichenoid skin damage …
Ponatinib is a third-generation TKI and the only kinase inhibitor effective in patients with certain BCR-ABL1 mutations, including the T315I mutation. However, ponatinib is associated with an …
Ponatinib Side Effects: Common, Severe, Long Term - Drugs.com
Learn about the side effects of ponatinib, from common to rare, for consumers and healthcare professionals.
A patient with maculopapular rash and lichenoid skin damage
Ponatinib is a third-generation TKI and the only kinase inhibitor effective in patients with certain BCR-ABL1 mutations, including the T315I mutation. However, ponatinib is associated with an …
A case of pityriasis rubra pilaris secondary to ponatinib - PMC
Ponatinib is known for causing several adverse effects, with cutaneous reactions being among the most common. According to the PACE trial, 47% patients experienced skin rashes, and 42% …
Side Effects of ICLUSIG® (ponatinib)
Get medical help right away if you get any of the following symptoms: shortness of breath, chest pain, fast or irregular heartbeats, dizziness, or feel faint. Liver problems. ICLUSIG can cause …
Ponatinib-induced atypical pityriasis rubra pilaris-like rash
The best evidence regarding frequency and management of skin toxicity due to ponatinib comes from few large randomized controlled trials such as the PACE trial in which dermatologic …
Ponatinib‐induced ichthyosiform eruption - PMC - National …
Skin rash and dry skin are extremely frequent during ponatinib phase 2 and 3 studies. Several cases of ichtyosiform rash have been described. Lesions may appear after a few weeks of …
Ponatinib-induced pityriasis rubra pilaris-like adnexal ...
Ponatinib, a third-generation tyrosine kinase inhibitor (TKI), is approved for the treatment of refractory chronic myeloid leukemia and Philadelphia chromosome-positive acute …
Ponatinib Induced Pityriasis Rubra Pilaris: Case Report and Review …
The most common adverse effect of ponatinib is skin rash and xerosis, seen in around half of the cases. Here, we present a case of PRP-like eruption in a patient receiving ponatinib for CML.